Unicycive Therapeutics, Inc. (UNCY) stock
UNCYNasdaqPharmaceutical PreparationsFiscal year ends December 31
$3.70+0.00 (0.00%)
Close on Nov 17, 2026Market cap $103.06MP/E –Yield –
Unicycive Therapeutics profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Unicycive Therapeutics's profit margin for the twelve months ending Dec 31, 2023 was -4525.0%. For fiscal 2023 it was -4525.0%, against -1898.8% the year before.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | -4525.0% | −2626.2 |
| FY2022 | Dec 31, 2022 | -1898.8% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q1 FY2023 | Mar 31, 2023 | -2159.3% | – |
| Q3 FY2022 | Sep 30, 2022 | -584.3% | – |
See a number that looks wrong?